 Immunome Inc NASDAQ: IMNM shares are trading higher after it published data demonstrating that its COVID-19 antibody cocktail, IMM-BCP-01, potently cleared the omicron variant BA.1 when tested in vivo in hamsters. Additional in vitro testing of a SARS-CoV-2 pseudovirus. 